Medical Weight Loss Treatment for Maryland Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the Maryland Board of Physicians to deliver telehealth services throughout the state.
Whether you're in Baltimore, Annapolis, or anywhere across Maryland — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Maryland
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Maryland bridges the nation's capital with the Chesapeake Bay's natural beauty. OmniRx Health serves this diverse state—from the federal workers of Montgomery County to the waterfront communities of the Eastern Shore, the professionals of Baltimore's Inner Harbor to the rural areas of Western Maryland. Our telehealth platform is perfect for busy Marylanders who want world-class care without the notorious DC-area traffic.
Available Treatments in Maryland
Our board-certified providers in Maryland can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Maryland
State Licensing
Our providers are licensed by the Maryland Board of Physicians to deliver telehealth services throughout the state.
Telehealth Law
Maryland has comprehensive telehealth laws that balance innovation with patient protection, supporting virtual care across the state.
Pharmacy Access
Maryland's extensive pharmacy network in Baltimore, DC suburbs, and throughout the state ensures rapid prescription access and delivery.
Insurance Notes
Maryland mandates telehealth coverage parity, requiring insurers to cover virtual visits at the same rate as in-person appointments.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Maryland
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.